Matrix Metalloproteinases: A Review of Their Structure and Role in Systemic Sclerosis
- 6 July 2012
- journal article
- review article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 32 (6) , 1409-1414
Abstract
Matrix metalloproteinases (MMPs) are the main enzymes involved in arterial wall extracellular matrix (ECM) degradation and remodeling, whose activity has been involved in various normal and pathologic processes, such as inflammation, fibrosis. As a result, the MMPs have come to consider as both therapeutic targets and diagnostic tools for the treatment and diagnosis of autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis. Systemic sclerosis (SSc) is a rare autoimmune disease of unknown etiology characterized by an excessive over-production of collagen and other ECM, resulting in skin thickening and fibrosis of internal organs. In recent years, abnormal expression of MMPs has been demonstrated with the pathogenesis of SSc, and the association of different polymorphisms on MMPs genes with SSc has been extensively studied. This review describes the structure, function and regulation of MMPs and shortly summarizes current understanding on experimental findings, genetic associations of MMPs in SSc.Keywords
This publication has 60 references indexed in Scilit:
- Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damageAnnals of the Rheumatic Diseases, 2012
- Association of a Functional Polymorphism in the Matrix Metalloproteinase-12 Promoter Region with Systemic Sclerosis in an Italian PopulationThe Journal of Rheumatology, 2010
- Association of Metalloproteinase Gene Polymorphisms with Systemic Sclerosis in the European Caucasian PopulationThe Journal of Rheumatology, 2010
- Systemic sclerosis and infectionsAutoimmunity Reviews, 2008
- Matrix metalloproteinases as modulators of inflammationSeminars in Cell & Developmental Biology, 2008
- Matrix Metalloproteinase Gene Delivery for Liver FibrosisPharmaceutical Research, 2007
- Function Blocking Autoantibodies Against Matrix Metalloproteinase-1 in Patients with Systemic SclerosisJournal of Investigative Dermatology, 2003
- Epidermal Growth Factor Receptor Signaling and the Invasive Phenotype of Ovarian Carcinoma CellsJNCI: Journal of the National Cancer Institute, 2001
- Lack of association of a functionally relevant single nucleotide polymorphism of matrix metalloproteinase-1 promoter with systemic sclerosis (scleroderma)Genes & Immunity, 2001
- Gelatinase B Is Required for Alveolar Bronchiolization after Intratracheal BleomycinThe American Journal of Pathology, 2000